rs1042391377
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004360.5(CDH1):c.55T>C(p.Ser19Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004360.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH1 | NM_004360.5 | c.55T>C | p.Ser19Pro | missense_variant | 2/16 | ENST00000261769.10 | NP_004351.1 | |
CDH1 | NM_001317184.2 | c.55T>C | p.Ser19Pro | missense_variant | 2/15 | NP_001304113.1 | ||
CDH1 | NM_001317185.2 | c.-1561T>C | 5_prime_UTR_variant | 2/16 | NP_001304114.1 | |||
CDH1 | NM_001317186.2 | c.-1765T>C | 5_prime_UTR_variant | 2/15 | NP_001304115.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH1 | ENST00000261769.10 | c.55T>C | p.Ser19Pro | missense_variant | 2/16 | 1 | NM_004360.5 | ENSP00000261769 | P1 | |
CDH1 | ENST00000422392.6 | c.55T>C | p.Ser19Pro | missense_variant | 2/15 | 1 | ENSP00000414946 | |||
CDH1 | ENST00000566612.5 | c.55T>C | p.Ser19Pro | missense_variant, NMD_transcript_variant | 2/15 | 1 | ENSP00000454782 | |||
CDH1 | ENST00000566510.5 | c.55T>C | p.Ser19Pro | missense_variant, NMD_transcript_variant | 2/15 | 5 | ENSP00000458139 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary diffuse gastric adenocarcinoma Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 19, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The proline amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with CDH1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 19 of the CDH1 protein (p.Ser19Pro). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.